1,535
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Oral roflumilast as a therapeutic option for psoriasis, what role does it have? Case report and literature review

, , &
Article: 2240456 | Received 23 May 2023, Accepted 19 Jul 2023, Published online: 25 Jul 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.